38235-77-7C[C@@H](NCc1ccccc1)c1ccccc1ZYZHMSJNPCYUTB-CYBMUJFWSA-N38235-77-7DTXSID50361451Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H302 (90%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 50 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Verwenden(R)-(+)-N-Benzyl-α-methylbenzylamine may be used to prepare:tert-Butyl (3S)-3-{benzyl[(1R)-1-phenylethyl]amino}-3-(6-methoxypyridin-3-yl)propanoate, an intermediate for the synthesis of the Merck & Co. Inc., Kenilworth, NJ, U.S. αvβ3 integrin antagonist.A conformationally restricted piperidine-based analog of deoxynegamycin.5- and 6-[2,3]-dihydrobenzofuran β-amino acids, which can act as aspartic acid mimetics.